
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1055 | 1070 | 1165 | 1254 | 1365 | 1857 |
Fund Return | 5.49% | 6.95% | 16.53% | 7.83% | 6.43% | 6.39% |
Place in category | 327 | 307 | 208 | 208 | 205 | 96 |
% in Category | 54 | 50 | 39 | 40 | 44 | 30 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust C Acc | 3.35B | 4.50 | 15.58 | 15.55 | ||
Legal General US Index Trust C Dist | 780.34M | 4.51 | 15.59 | 15.55 | ||
Legal General US Index Trust I Acc | 1.54B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust I Dist | 1.59B | 27.16 | 11.15 | 15.07 | ||
Legal General US Index Trust F Acc | 515.94K | 4.46 | 15.26 | 15.22 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.83B | 6.89 | 8.27 | 6.15 | ||
All Share Index Unit Trust Income | 14.83B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 14.83B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 14.83B | 9.34 | 5.75 | 6.11 | ||
UK Equity Tracker Fund X Acc | 12.42B | 6.05 | 8.78 | 6.27 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Shell | GB00BP6MXD84 | 6.49 | 33.58 | -1.50% | |
AstraZeneca | GB0009895292 | 6.32 | 11,416.0 | +1.96% | |
HSBC | GB0005405286 | 5.99 | 885.40 | -0.90% | |
Unilever | GB00B10RZP78 | 4.69 | 54.86 | +1.22% | |
Relx | GB00B2B0DG97 | 2.84 | 3,887.00 | +0.70% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review